166 related articles for article (PubMed ID: 8189072)
1. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy.
López D; García-Hoyo R; López de Castro JA
J Immunol; 1994 Jun; 152(11):5557-71. PubMed ID: 8189072
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
3. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity.
López D; Rojo S; Calvo V; López de Castro JA
J Immunol; 1992 Feb; 148(4):996-1002. PubMed ID: 1371137
[TBL] [Abstract][Full Text] [Related]
4. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
García-Peydró M; Martí M; López de Castro JA
J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.
Czitrom AA; Pototschnik R; Edwards S; Gladman DD; Falk JA
Exp Clin Immunogenet; 1986; 3(3):129-37. PubMed ID: 2484102
[TBL] [Abstract][Full Text] [Related]
6. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
Calvo V; Rojo S; López D; Galocha B; López de Castro JA
J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
[TBL] [Abstract][Full Text] [Related]
7. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705.
Villadangos JA; Galocha B; García-Hoyo R; López D; García F; López de Castro JA
Eur J Immunol; 1994 Oct; 24(10):2548-55. PubMed ID: 7523146
[TBL] [Abstract][Full Text] [Related]
8. B*2707 differs in peptide specificity from B*2705 and B*2704 as much as from HLA-B27 subtypes not associated to spondyloarthritis.
Gómez P; Montserrat V; Marcilla M; Paradela A; de Castro JA
Eur J Immunol; 2006 Jul; 36(7):1867-81. PubMed ID: 16783853
[TBL] [Abstract][Full Text] [Related]
9. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
[TBL] [Abstract][Full Text] [Related]
10. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity.
Rojo S; López D; Calvo V; López de Castro JA
J Immunol; 1991 Jan; 146(2):634-42. PubMed ID: 1702810
[TBL] [Abstract][Full Text] [Related]
11. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
[TBL] [Abstract][Full Text] [Related]
12. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition.
Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA
J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067
[TBL] [Abstract][Full Text] [Related]
13. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
[TBL] [Abstract][Full Text] [Related]
14. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
[TBL] [Abstract][Full Text] [Related]
15. T cell allorecognition and endogenous HLA-B27-bound peptides in a cell line with defective HLA-B27-restricted antigen presentation.
López D; García-Hoyo R; García F; López de Castro JA
Eur J Immunol; 1994 May; 24(5):1194-9. PubMed ID: 8181529
[TBL] [Abstract][Full Text] [Related]
16. [HLA-B27 molecular subtypes and spondylarthropathies].
Tieng V; Charron D; Toubert A
Pathol Biol (Paris); 1998 Dec; 46(10):737-40. PubMed ID: 9922989
[TBL] [Abstract][Full Text] [Related]
17. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity.
Paradela A; García-Peydró M; Vázquez J; Rognan D; López de Castro JA
J Immunol; 1998 Nov; 161(10):5481-90. PubMed ID: 9820524
[TBL] [Abstract][Full Text] [Related]
18. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
Ugrinovic S; Mertz A; Wu P; Braun J; Sieper J
J Immunol; 1997 Dec; 159(11):5715-23. PubMed ID: 9548516
[TBL] [Abstract][Full Text] [Related]
19. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
Villadangos JA; Galocha B; López de Castro JA
J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
[TBL] [Abstract][Full Text] [Related]
20. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.
Boisgérault F; Tieng V; Stolzenberg MC; Dulphy N; Khalil I; Tamouza R; Charron D; Toubert A
J Clin Invest; 1996 Dec; 98(12):2764-70. PubMed ID: 8981922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
